Superdrug announced FY2025 results on 7 July 2026: sales of £1.7bn (+5.2%), pre-tax profit of £144.1m (+5.3%), against what the company described as a challenging retail backdrop. Bundled with the results were three simultaneous own-brand launches and the UK launch of Australian social-first brand MCoBeauty into Superdrug stores. Source: The Retail Bulletin, "Superdrug sales up 5.2% despite challenging backdrop," 7 July 2026 (https://www.theretailbulletin.com/health-and-beauty/superdrug-sales-up-5-2-despite-challenging-backdrop-07-07-2026/).
The results themselves are a story about a well-run mass pharmacy chain quietly outperforming a soft category. The far more useful story for a £500k-£5m beauty founder is which brand landed alongside the numbers, and why.
MCoBeauty is Australian, founded on social-first marketing, priced against dupe expectations (usually £5 to £15 at retail), and known for viral makeup and skincare that trends on TikTok before it lands on shelf. It has grown fast in Australia through Chemist Warehouse, in the US through Kroger and Target, and now enters the UK through Superdrug as its first major physical distribution. Five years ago that positioning would have been a pitch that never left the buyer's inbox. This month it is the shape of a warm deal.
What the UK mass pharmacy channel looks like now
For most of the last decade, Boots and Superdrug were the anchor doors of UK "health and beauty," with a large functional segment (medicines, gifting, seasonal) and a beauty section that mostly stocked drugstore skincare, drugstore colour, and a handful of premium tiers behind glass.
That model has been shifting for five years. Boots' Premium bays now carry Charlotte Tilbury (in 31 stores from 3 July 2026), Fenty Beauty, Trinny London, and other properties that would once have been considered department-store or specialty-only. Superdrug has been aggressive with its own-brand tiers, filling shelf that would have been distributed brand-heavy in previous eras, while opening real space to social-first indies. Both chains are now competing directly with Sephora UK for premium and social-first customer acquisition, not with each other for functional footfall.
The Superdrug results are only the most recent proof. FY2025 sales up 5.2% is not remarkable in isolation. It is remarkable next to how much category volume is contracting elsewhere. Superdrug is gaining share because it is buying the right brands, running its own-brand shelf efficiently, and letting price and social lead the conversation, rather than defending a decade-old category planogram.
Why MCoBeauty is the useful case study
MCoBeauty did not land at Superdrug through a slow-cook prestige pitch. It landed because its inputs were legible.
Social velocity. MCoBeauty has demonstrable virality on TikTok and Instagram, driven by dupe framing of prestige products and creator content. That is not a marketing narrative. It is a measurable series of GMV, followers, and creator-led sell-through data. UK mass pharmacy buyers can read that data now in a way they could not five years ago.
Priced to move at volume. MCoBeauty is not asking Superdrug to protect a £45 SKU. It is asking Superdrug to move £5-£15 units at pace. That is aligned with Superdrug's own-brand and prestige-mix strategy, and the retailer knows exactly how to merchandise it.
Retail-ready. Australian and US distribution proved MCoBeauty can service a large physical retail account without inventory or fulfilment failures. That is a specific credential UK buyers can check.
Those three inputs are exactly what a £500k-£5m UK indie founder can build. They are not "years of prestige credibility." They are social data, DTC economics, and retail operations. Two out of three is normal for a growing indie. The third is often the missing piece, and it is a piece that can be closed in six months of deliberate work.
The current UK mass pharmacy pitch spec
The two-page pitch that lands warmly at Superdrug or Boots in 2026 has a specific structure. It is worth writing to the actual spec, not to a generic wholesale template.
Page one, section one: social velocity. TikTok Shop GMV run rate, monthly creator programme scale, EMV or equivalent, top three viral moments in the last twelve months with sell-through evidence. If you can show 200-plus active creators, month-on-month GMV growth on TikTok Shop, and a repeatable content engine, this section closes itself.
Page one, section two: DTC unit economics. Gross margin after all COGS and fulfilment, thirty-day repeat rate, sixty-day repeat rate, twelve-month LTV to CAC. Do not send a deck that hides these. Buyers can already model them from your public data; sending them cleanly is the fastest credibility win.
Page two, section three: retail readiness. Fulfilment SLA, minimum weekly restock cadence, promotional co-funding tolerance for your top three SKUs, samples policy, in-store education plan, and evidence of prior retail execution (Amazon, Cult Beauty, small independents). This is often where indies fall short. It is also where the door either opens or closes.
Page two, section four: category expansion story. Not a five-year plan. A specific six to twelve month roadmap of one flagship SKU expansion, one seasonal moment, one influencer partnership, and one exclusive retailer window (if the retailer wants it). Buyers now value tight, executable roadmaps over aspirational category plans.
What the £500k-£5m founder should do this month
Rank your channels. If UK mass pharmacy is not currently on your channel plan, add it as an evaluation line. If it is on your channel plan under "long-term aspiration," move it forward to "twelve-month decision."
Audit your pitch against the current spec. Most existing UK indie decks are built to the 2022 spec. They lead with brand story, mission, and celebrity endorsements. That deck now underperforms a deck that leads with TikTok Shop GMV growth and a fulfilment SLA. Buyers are commercial in 2026 in a way they were not before.
Build the missing piece. If you are strong on social and DTC but light on retail readiness, close that gap in the next quarter. That means firming up your 3PL relationship, publishing a real fulfilment SLA, mapping promotional co-funding capacity by SKU, and running one small physical retail pilot with a Cult Beauty, an Amazon Beauty, or a specialty account to prove operational competence.
Do not wait for an introduction. Superdrug and Boots buyers are actively reviewing indie brands with legible social data and clean unit economics. The correct move is a direct approach with a two-page pitch built to the current spec. Warm introductions still help, but they are no longer the gating factor. Legibility of the numbers is.
The wider frame
Charlotte Tilbury landing in 31 Boots stores in early July, and MCoBeauty landing in Superdrug in the same week, are not coincidences. Two of the UK's biggest mass pharmacy chains are simultaneously widening their prestige and social-first brand mix. They are competing with Sephora UK and with each other for the same customer, and they are willing to open shelf to any brand that can prove the mix works.
The UK indie founders who read this correctly and pitch to the current spec will be on Superdrug or Boots shelf inside twelve months. The founders still building a 2022-shaped wholesale deck will spend twelve more months explaining why they were passed over. The door is open. The specification is published. The work is to pitch to it.